The role of stromal cells in prostate cancer development and progression

In Vivo

Volumn 13, Issue 1, 1999, Pages 61-65

  Condon, Mark S ^a,b   Bosland, Maarten C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUNY Dutchess Community College   (United States)

Author keywords

Mesenchyme; Prostate; Prostate cancer; Stromal epithelial interactions

Indexed keywords

ANDROGEN RECEPTOR; HUMORAL ANTIBODY; KERATINOCYTE GROWTH FACTOR; STEROID HORMONE;

ANIMAL CELL; CANCER GROWTH; CANCER STAGING; DOG; EPITHELIUM CELL; FIBROBLAST; HUMAN; MALE; MESENCHYME; NONHUMAN; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; RAT; REVIEW; SEMINAL VESICLE; STROMA CELL; UROGENITAL SINUS;

EID: 0032897447     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer Statistics, 1998. CA Cancer J Clin 48: 6-29, 1998.
2. Bosland MC: The etiopathogenesis of prostate cancer with special reference to environmental factors. Adv Cancer Res 51: 1-106, 1988.
3. Skar WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJE and Haas GP: High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: An autopsy study of 249 cases. In Vivo 8: 439-444, 1994.
4. Nomura AMY, Kolonel LN: Prostate cancer: A current perspective. Epidemiol Rev 13: 200-207, 1991.
5. Gleave M, Hsieh JT, Gao C, von Eschenbach AC and Chung LWK: Alteration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 51: 3753-3761, 1991.
6. Hullinger TG, McCauley LK, DeJoode ML and Somerman MJ: Effects of bone proteins on human prostate cancer cell lines in vitro. The Prostate 36: 1422, 1998.
7. Grobstein C: Epithelio-mesenchymal specificity in the morphogenesis of mouse sub- mandibular rudiments in vitro. J Exp Zoo 124: 383-413, 1953.
8. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM and Higgins SJ: The endocrinology and developmental biology of the prostate. Endocrine Rev 8: 338-363, 1987.
9. Wilson JD, George FW and Griffin JE: The hormonal control of sexual development. Science 211: 1278-1284, 1981.
10. Lasnitzki I and Mizuno T: Role of the mesenchyme in the induction of the rat prostate gland by androgens in organ culture. J Endocrinol 82: 171-178, 1979.
11. Cunha GR, Chung LWK, Shannon JM and Reese BA: Stromal-epithelial interactions in sex differentiation. Biol Reprod 22: 19-42, 1980.
12. Isaacs JT and Coffey DS: Androgenic control of prostatic growth: Regulation of steroid levels. UICC Monograph (Prostatic Cancer) 48: 112-122, 1979.
13. Tenniswood M: Role of stromal-epithelial interactions in the control of gene expression in the prostate: a hypothesis. The Prostate 9: 375-385, 1986.
14. Heyns W Van Damme B and De Moor P: Secretion of prostate binding protein by rat ventral prostate: influence of age and androgen. Endocrinol 103: 1090-1095, 1977.
15. Thompson TC, Zhau H and Chung LWK: Catecholamines are involved in the growth and expression of prostatic binding protein by rat ventral prostatic tissue. In: Current concepts and approaches to the study of prostate cancer (Coffey DS, Bruchovsky N, Gardner WA jr, Resnick MI and Karr JP, eds). New York, Alan R. Liss, 1987, pp 239-248.
16. Nevalainen MT, Valve EM, Makela SI, Blauer M, Tuohimaa PJ and Harkonen: Estrogen and prolactin regulation of rat dorsal and lateral prostate in organ culture. Endocrinol 129: 612-622, 1991.
17. Smith RG, Syms AJ, Nag A, Lerner S and Norris JS: Mechanism of the glucocorticoid regulation of growth of the androgen-sensitive prostate derived R3327H-G8-A1 tumor cell line. J Biol Chem 260: 12454-12463, 1985.
18. McKeehan WL, Adams PS and Rosser MP: Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum- free, primary cell culture. Cancer Res 4: 1998-2010, 1984.
19. Ulrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A 431 epidermoid carcinoma cells. Nature 309: 418-424, 1984.
20. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G and Klocker H: Regulation of prostatic growth and function by peptide growth factors. The Prostate 28: 392-405, 1996.
21. Timme TL, Truong LD, Merz VW, Krebs T, Kadmon DK, Flanders KC, Park SH and Thompson TC: Mesenchymal-epithelial interactions and transforming growth factor-13 during mouse prostate morphogenesis. Endocrinol 134: 1039-1045, 1994.
22. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT and Thompson TC: Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical study. Human Pathol 24: 4-9, 1993.
23. Yang G, Timme TL, Park SH and Thompson TC: Transforming growth factor β1 transduced mouse prostate reconstitutions: I. Induction of neural phenotypes. The Prostate, 33: 151-156, 1997.
24. Watts RG and Ware JL: Isolation and characterization of transforming growth factor beta response variants from human prostatic tumor cell lines. The Prostate 21: 223- 237, 1992.
25. Sugimura Y, Foster BA, Hom YK, Lipschutz JH, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J and Cunha GR: Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 40: 941-951, 1996.
26. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA and Cunha GR: Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91: 1074-1078, 1994.
27. Culig Z, Hobisch A, Cronauer MV, Radmayr C and Trapman J: Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54: 5474-5478, 1994.
28. Canatan H, Shidaifat F, Kulp SK, Zhang Y, Chang WY, Brueggemeir RW and Lin YC: Differential effect of keratinocyte growth factor (KGF) on aromatase activity in cultures canine prostatic epithelial cells. Endocrine Res 23: 311-323, 1997.
29. Verhoeven G, Swinnen K, Cailleau J, Deboel L, Rombauts L and Heyns W: The role of cell-cell interactions in androgen action. J Steroid Biochem Mol Biol 41: 487-494, 1992.
30. Ruddon RW: Cancer Biology. New York, Oxford University Press, 1987.
31. Hayashi N and Cunha GR: Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma. Cancer Res 51: 4924-4930, 1991.
32. Kabalin JN, Peehl DM and Stamey TA: Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts, The Prostate 14: 251-263, 1989.
33. Kooistra A, Konig JJ, Keizer DM, Romijn JC and Schroder FH: Inhibition of prostatic epithelial cell proliferation by a factor secreted specifically by prostatic stromal cells, The Prostate 26:123-132, 1995.
34. Chung LWK, Chang S, Bell C, Zhau HE, Ro JY and von Eschenbach AC: Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. Int J Cancer 43: 1179-1187, 1989.
35. Bosland MC: Chemical and hormonal induction of prostate cancer in animal models. Urol Oncol 2: 103-110, 1997.
36. Condon MS, Kaplan LAE., VanCleef K and Bosland MC: An in vitro model of prostate cancer progression. Proceedings of the American Association for Cancer Res 37: 155, 1996.
37. Condon MS: Stromal-epithelial interactions in prostate carcinogenesis. Doctoral dissertation. UMI Dissertation Services, Ann Arbor, MI, 1997.